These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 32222585)

  • 1. Glycosylation of Fcγ receptors influences their interaction with various IgG1 glycoforms.
    Cambay F; Forest-Nault C; Dumoulin L; Seguin A; Henry O; Durocher Y; De Crescenzo G
    Mol Immunol; 2020 May; 121():144-158. PubMed ID: 32222585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD16a with oligomannose-type
    Subedi GP; Barb AW
    J Biol Chem; 2018 Oct; 293(43):16842-16850. PubMed ID: 30213862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fc gamma receptor glycosylation modulates the binding of IgG glycoforms: a requirement for stable antibody interactions.
    Hayes JM; Frostell A; Cosgrave EF; Struwe WB; Potter O; Davey GP; Karlsson R; Anneren C; Rudd PM
    J Proteome Res; 2014 Dec; 13(12):5471-85. PubMed ID: 25345863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Fc Gamma Receptor Glycoforms That Produce Differential Binding Kinetics for Rituximab.
    Hayes JM; Frostell A; Karlsson R; Müller S; Martín SM; Pauers M; Reuss F; Cosgrave EF; Anneren C; Davey GP; Rudd PM
    Mol Cell Proteomics; 2017 Oct; 16(10):1770-1788. PubMed ID: 28576848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of
    Van Coillie J; Schulz MA; Bentlage AEH; de Haan N; Ye Z; Geerdes DM; van Esch WJE; Hafkenscheid L; Miller RL; Narimatsu Y; Vakhrushev SY; Yang Z; Vidarsson G; Clausen H
    Front Immunol; 2022; 13():987151. PubMed ID: 36189205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-linked glycan structures of the human Fcγ receptors produced in NS0 cells.
    Cosgrave EF; Struwe WB; Hayes JM; Harvey DJ; Wormald MR; Rudd PM
    J Proteome Res; 2013 Aug; 12(8):3721-37. PubMed ID: 23777450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of N-glycosylation on Fcγ receptor / IgG interactions: unravelling differences with an enhanced surface plasmon resonance biosensor assay based on coiled-coil interactions.
    Cambay F; Henry O; Durocher Y; De Crescenzo G
    MAbs; 2019 Apr; 11(3):435-452. PubMed ID: 30822189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-Angle Effector Function Analysis of Human Monoclonal IgG Glycovariants.
    Dashivets T; Thomann M; Rueger P; Knaupp A; Buchner J; Schlothauer T
    PLoS One; 2015; 10(12):e0143520. PubMed ID: 26657484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Site-Specific Glycosylation Analysis of Murine and Human Fcγ Receptors Reveals High Heterogeneity at Conserved
    Pavan CH; Abdoollah Z; Marrero Roche DE; Ryan HR; Moore E; Chandler KB
    J Proteome Res; 2024 Mar; 23(3):1088-1101. PubMed ID: 38363599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of site-distinct N-glycan variants for in vitro bioactivity testing.
    Brühlmann D; Vuillemin T; Satwekar A; Galano E; Palmese A; D'Angelo A; Manco Z; Souquet J; Broly H; Sauer M; Hemberger J; Jordan M
    Biotechnol Bioeng; 2019 May; 116(5):1017-1028. PubMed ID: 30659587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Site-specific N-glycan Analysis of Antibody-binding Fc γ Receptors from Primary Human Monocytes.
    Roberts JT; Patel KR; Barb AW
    Mol Cell Proteomics; 2020 Feb; 19(2):362-374. PubMed ID: 31888963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immunoglobulin G1 N-glycan composition affects binding to each low affinity Fc γ receptor.
    Subedi GP; Barb AW
    MAbs; 2016; 8(8):1512-1524. PubMed ID: 27492264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro glycoengineering of IgG1 and its effect on Fc receptor binding and ADCC activity.
    Thomann M; Schlothauer T; Dashivets T; Malik S; Avenal C; Bulau P; Rüger P; Reusch D
    PLoS One; 2015; 10(8):e0134949. PubMed ID: 26266936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-targeted characterization of attributes affecting antibody-FcγRIIIa V158 (CD16a) binding via online affinity chromatography-mass spectrometry.
    Woodall DW; Dillon TM; Kalenian K; Padaki R; Kuhns S; Semin DJ; Bondarenko PV
    MAbs; 2022; 14(1):2004982. PubMed ID: 34978527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conserved FcγR- glycan discriminates between fucosylated and afucosylated IgG in humans and mice.
    Dekkers G; Bentlage AEH; Plomp R; Visser R; Koeleman CAM; Beentjes A; Mok JY; van Esch WJE; Wuhrer M; Rispens T; Vidarsson G
    Mol Immunol; 2018 Feb; 94():54-60. PubMed ID: 29268168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody Fucosylation Lowers the FcγRIIIa/CD16a Affinity by Limiting the Conformations Sampled by the N162-Glycan.
    Falconer DJ; Subedi GP; Marcella AM; Barb AW
    ACS Chem Biol; 2018 Aug; 13(8):2179-2189. PubMed ID: 30016589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FcRn, but not FcγRs, drives maternal-fetal transplacental transport of human IgG antibodies.
    Borghi S; Bournazos S; Thulin NK; Li C; Gajewski A; Sherwood RW; Zhang S; Harris E; Jagannathan P; Wang LX; Ravetch JV; Wang TT
    Proc Natl Acad Sci U S A; 2020 Jun; 117(23):12943-12951. PubMed ID: 32461366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biophysical Evaluation of Rhesus Macaque Fc Gamma Receptors Reveals Similar IgG Fc Glycoform Preferences to Human Receptors.
    Crowley AR; Osei-Owusu NY; Dekkers G; Gao W; Wuhrer M; Magnani DM; Reimann KA; Pincus SH; Vidarsson G; Ackerman ME
    Front Immunol; 2021; 12():754710. PubMed ID: 34712242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary Human Natural Killer Cells Retain Proinflammatory IgG1 at the Cell Surface and Express CD16a Glycoforms with Donor-dependent Variability.
    Patel KR; Nott JD; Barb AW
    Mol Cell Proteomics; 2019 Nov; 18(11):2178-2190. PubMed ID: 31467031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced Effector Functions Due to Antibody Defucosylation Depend on the Effector Cell Fcγ Receptor Profile.
    Bruggeman CW; Dekkers G; Bentlage AEH; Treffers LW; Nagelkerke SQ; Lissenberg-Thunnissen S; Koeleman CAM; Wuhrer M; van den Berg TK; Rispens T; Vidarsson G; Kuijpers TW
    J Immunol; 2017 Jul; 199(1):204-211. PubMed ID: 28566370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.